Cargando…
The incorporation loci of H3.3K36M determine its preferential prevalence in chondroblastomas
The histone H3.3K36M mutation, identified in over 90% of chondroblastoma cases, reprograms the H3K36 methylation landscape and gene expression to promote tumorigenesis. However, it’s still unclear how the H3K36M mutation preferentially occurs in the histone H3 variant H3.3 in chondroblastomas. Here,...
Autores principales: | Zhang, Yanjun, Fang, Dong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7991640/ https://www.ncbi.nlm.nih.gov/pubmed/33762579 http://dx.doi.org/10.1038/s41419-021-03597-9 |
Ejemplares similares
-
H3.3 K36M Mutation as a Clinical Diagnosis Method of Suspected Chondroblastoma Cases
por: Mu, Haoran, et al.
Publicado: (2021) -
The H3.3 K36M oncohistone disrupts the establishment of epigenetic memory through loss of DNA methylation
por: Sinha, Joydeb, et al.
Publicado: (2023) -
Histone H3.3 phosphorylation promotes heterochromatin formation by inhibiting H3K9/K36 histone demethylase
por: Udugama, Maheshi, et al.
Publicado: (2022) -
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma
por: Voon, Hsiao P. J., et al.
Publicado: (2018) -
The cysteine-rich domain of TET2 binds preferentially to mono- and dimethylated histone H3K36
por: Yamagata, Kazuyuki, et al.
Publicado: (2017)